Form 8-K - Current report:
SEC Accession No. 0001437749-25-023352
Filing Date
2025-07-24
Accepted
2025-07-24 09:05:12
Documents
17
Period of Report
2025-07-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250723d_8k.htm   iXBRL 8-K 44418
2 EXHIBIT 4.1 ex_842762.htm EX-4.1 54388
3 EXHIBIT 10.1 ex_842763.htm EX-10.1 436843
4 EXHIBIT 10.2 ex_842764.htm EX-10.2 125374
5 EXHIBIT 99.1 ex_842833.htm EX-99.1 9998
  Complete submission text file 0001437749-25-023352.txt   931285

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20250723.xsd EX-101.SCH 3580
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250723_def.xml EX-101.DEF 11808
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250723_lab.xml EX-101.LAB 15859
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250723_pre.xml EX-101.PRE 12023
19 EXTRACTED XBRL INSTANCE DOCUMENT wint20250723d_8k_htm.xml XML 2949
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 251144723
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)